Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
OmniComm Systems, Inc., a global provider of clinical data management technology, has announced that one of the top 5 medical research universities in the US, selected OmniComm TrialMaster® EDC and related services to conduct a series of clinical ...
read more
Wednesday, November 27, 2019
OmniComm Systems has announced its release of IRTMaster Version 5.2, an enhanced product offering to complement their comprehensive eClinical suite.
read more
Omnicell, Inc., a leading provider of medication management solutions and adherence tools for health systems and pharmacies, announced a definitive agreement with pharmacy software solutions provider FDS Amplicare to acquire its business for total ...
read more
OmniaBio Inc. announced the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of excellence, which is now Canada's largest contract development and manufacturing organization (CDMO) ...
read more
Thursday, October 02, 2025
OmniaBio, a next generation contract development and manufacturing organization (CDMO) pioneering the manufacturing of cell and gene therapies (CGT) with robotics and artificial intelligence, and BrainChild Bio Inc, a clinical-stage biotechnology ...
read more
Omeros and Lonza announced a long-term manufacturing agreement for commercial production of narsoplimab, also referred to as OMS721.
read more
Olon S.p.A., an Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, has announced the acquisition of Ricerca Biosciences' Chemical Division of the contract research (CRO) and CDMO ...
read more
Monday, February 04, 2019
Olon S.p.A. announced the acquisition of Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation, as part of a continuing expansion of its global footprint.
read more
Olon S.p.A. announced the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
read more
Tuesday, September 04, 2018
Olon S.p.A. announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.
read more
Ology Bioservices and Rafa Laboratories announced they received full approval from the FDA for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector.
read more
Ology Bioservices and Inovio announced the DOD has awarded Ology Bioservices with a contract to work with Inovio on DNA technology transfer to rapidly manufacture DNA vaccines.
read more
Ology Bioservices announced the Department of Defense has awarded the company with two contracts valued at $135.4 million.
read more
Oligo Factory, a provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, diagnostic, and life science applications, announced the launch of its new low-scale oligo synthesis capability. This expansion enhances the company’s ...
read more
Ofichem, a European CDMO specializing in active pharmaceutical ingredients (APIs) and integrated drug development and manufacturing services, announced the acquisition of Meribel Pharma Solutions’ site in Uppsala, Sweden. This strategic step enhances...
read more